| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 16, 2001
Revised on January 14, 2002
Accepted on January 14, 2002
From the Cardiovascular Research Group, Molecular and Cellular Cardiology Laboratories, Temple University School of Medicine, Philadelphia, Pa.
* To whom correspondence should be addressed. E-mail: srhouser{at}unix.temple.edu.
Phosphorylation of Na channels has been suggested to increase their Ca permeability. Termed "Slip-Mode Conductance" (SMC), this hypothesis predicts that Ca influx via protein kinase A (PKA)--modified Na channels can induce sarcoplasmic reticulum (SR) Ca release. We tested this hypothesis by determining if SR Ca release is graded with INa in the presence of activated PKA (with Isoproterenol, ISO). Vm, Im, and [Ca]i were measured in feline (n=26) and failing human (n=19) ventricular myocytes. Voltage steps from -70 through -40 mV were used to grade INa. Na channel antagonists (tetrodotoxin), L-type Ca channel (ICa,L) antagonists (nifedipine, cadmium, Verapamil), and agonists (Bay K 8644, FPL 64176) were used to separate SMC from ICa,L. In the absence of ISO, INa was associated with SR Ca release in human but not feline myocytes. After ISO, graded INa was associated with small amounts of SR Ca release in feline myocytes and the magnitude of release increased in human myocytes. INa-related SR Ca release was insensitive to tetrodotoxin (n=10) but was blocked by nifedipine (n=10) and cadmium (n=3). SR Ca release was induced over the same voltage range in the absence of ISO with Bay K 8644 and FPL 64176 (n=9). Positive voltage steps (to 0 mV) to fully activate Na channels (SMC) in the presence of ISO and Verapamil only caused SR Ca release when block of ICa,L was incomplete. We conclude that PKA-mediated increases in ICa,L and SR Ca loading can reproduce many of the experimental features of SMC.
This article has been cited by other articles:
![]() |
H. K. Saini and N. S. Dhalla Sarcolemmal cation channels and exchangers modify the increase in intracellular calcium in cardiomyocytes on inhibiting Na+-K+-ATPase Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H169 - H181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Altamirano, Y. Li, J. DeSantiago, V. Piacentino 3rd, S. R. Houser, and D. M. Bers The inotropic effect of cardioactive glycosides in ventricular myocytes requires Na+-Ca2+ exchanger function J. Physiol., September 15, 2006; 575(3): 845 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jung, R. Harrison, K. H. Lee, J. Genut, D. Nyhan, E. M. Brooks-Asplund, A. A. Shoukas, J. M. Hare, and D. E. Berkowitz Simulated microgravity produces attenuated baroreflex-mediated pressor, chronotropic, and inotropic responses in mice Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H600 - H607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jung, M. P. Quaile, G. D. Mills, D. P. Bednarik, S. R. Houser, and K. B. Margulies Pharmacological Effects of ATI22-107 [2-(2-{2-[2-Chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic Acid Dimethyl Ester)], a Novel Dual Pharmacophore, on Myocyte Calcium Cycling and Contractility J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Alvarez, E. Salinas-Stefanon, G. Orta, T. Ferrer, K. Talavera, L. Galan, and G. Vassort Occurrence of a tetrodotoxin-sensitive calcium current in rat ventricular myocytes after long-term myocardial infarction Cardiovasc Res, September 1, 2004; 63(4): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Piacentino III, C. R. Weber, X. Chen, J. Weisser-Thomas, K. B. Margulies, D. M. Bers, and S. R. Houser Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes Circ. Res., April 4, 2003; 92(6): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H.G Schwinger, H. Bundgaard, J. Muller-Ehmsen, and K. Kjeldsen The Na, K-ATPase in the failing human heart Cardiovasc Res, March 15, 2003; 57(4): 913 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Hilgemann From a pump to a pore: How palytoxin opens the gates PNAS, January 21, 2003; 100(2): 386 - 388. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |